跳至主要内容
临床试验/NCT03260231
NCT03260231Unknown不适用

Effects of Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma

University of Belgrade2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年5月12日最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
2
主要终点
Change in disease status

研究概览

简要总结

Recent literature data suggest beneficial effects of dietary fats in patients with cancers, in particular polyunsaturated fatty acids (PUFAs). Milled mix of flax, sesame and pumpkin seeds provides a high amount of PUFAs and a desirable n-6/n-3 PUFAs ratio.

详细描述

Cancers are characterized by inflammation and alternations in lipid and fatty acid metabolism. Patients with non-Hodgkin lymphoma have impaired fatty acid profiles, low level of PUFAs, and high n-6/n-3 PUFAs ratio. Moreover, these changes are related to clinical outcome.

Flax seeds, sesame and pumpkin seeds are rich sources of PUFAs. Dietary intake of milled mix of these seeds has been shown to decrease inflammation and improve PUFAs status in patients on hemodialysis and to decrease breast cancer risk.

The study design is single-blind, controlled, randomized nutritional intervention. The participants are randomly assigned into intervention and control group before starting chemotherapy. All patients receive nutritional counseling to achieve a daily energy and protein intake according to recommended dietary allowances, with (intervention) or without (control) of milled seed mix.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Investigator)

盲法说明

Single blind

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologically confirmed Non-Hodgkin lymphoma
  • Patients able to understand requirements of the study and provide written informed consent

排除标准

  • Previous radio- or chemotherapy
  • Other serious chronic diseases
  • Statin therapy
  • Presence of allergy on any seeds
  • Use of fat-based dietary supplements (such as fish oil, evening primrose oil etc) 3 months prior to study

结局指标

主要结局

Change in disease status

时间窗: Baseline, 5 months, 1 year

Remission, stable disease or progression

Change in quality of life questionnaire scores

时间窗: Baseline, 5 months, 1 year

Assessed by standardized questionnaires

次要结局

  • Changes in interleukin (IL)-6(Baseline, 5 months, 1 year)
  • Changes in plasma fatty acids(Baseline, 5 months, 1 year)
  • Changes in leukocyte count(Baseline, 5 months, 1 year)
  • Changes in lipid profiles(Baseline, 5 months, 1 year)
  • Changes in body weight(Baseline, 5 months, 1 year)
  • Changes in CRP(Baseline, 5 months, 1 year)
  • Changes in parameters of oxidative stress(Baseline, 5 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vesna Vucic

Professor of Research

University of Belgrade

研究点 (2)

Loading locations...

相似试验